On March 8, 2022  Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics, reported that CEO Masoud Tavazoie, M.D., Ph.D., will participate in multiple virtual healthcare investor conferences taking place during the month of March (Press release, Inspirna, MAR 8, 2022, View Source [SID1234609653]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 32nd Annual Healthcare Conference
Presentation on March 17, 2022, at 2:40 P.M. EST

SVB Leerink Biopharma Private Company Connect
Hosting meetings March 29-31

Links to the live and archived versions of the presentation will be available on Inspirna’s website under the News section.